This protocol is judged by an institutional evaluation board, an impartial team that critiques any clinical trials involving individuals. If a study requires a Schedule I drug, when the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) amount with the FDA.Medicines can also incorporate unfa